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Vestibular Stimulation for ADHD: Randomized Controlled Trial of 
Comprehensive Motion Apparatus 
L. Eugene Arnold, Lindsay Crowl, Hernan Bozzolo, Mario Peruggia, Yaser 
Ramadan, Robert Bornstein, Jill A. Hollway, Susan Thompson, Krista Malone, 
Kristy L. Hall, Sara B. Shelton, Dawn R. Bozzolo, Amy Cook, David L. Clark, The 
Ohio State University 
Objective: 
This research evaluates effects of vestibular stimulation by Comprehensive Motion Apparatus 
(CMA) in ADHD. 
Method: 
Children ages 6 to 12 (48 boys, 5 girls) with ADHD were randomized to thrice-weekly 30-min 
treatments for 12 weeks with CMA, stimulating otoliths and semicircular canals, or a single-blind control of 
equal duration and intensity, each treatment followed by a 20-min typing tutorial. 
Results: 
In intent-to-treat analysis (n = 50), primary outcome improved significantly in both groups (p = 
.0001, d = 1.09 to 1.30), but treatment difference not significant (p = .7). Control children regressed by 
follow-up (difference p = .034, d = 0.65), but overall difference was not significant (p = .13, d = .47). No 
measure showed significant treatment differences at treatment end, but one did at follow-up. Children with 
IQ-achievement discrepancy ≥ 1 SD showed significantly more CMA advantage on three measures. 
Conclusion: 
This study illustrates the importance of a credible control condition of equal duration and intensity 
in trials of novel treatments. CMA treatment cannot be recommended for combined-type ADHD without 
learning disorder. (J. of Att. Dis. 2008; 11(5) 599-611) 
This report evaluates a device for providing motion stimulation to both the semicircular 
canals and the otolith structures (utricles and saccules) of the inner-ear vestibules as a treatment 
for ADHD. ADHD is a syndrome of age-inappropriate inattention, distractibility, impulsivity, 
and restless overactivity (American Psychiatric Association, 2000; National Institutes of Health, 
1998). Almost half (30% to 50%) of children with ADHD exhibit poor balance and coordination 
(Blondis, 1999; Piek, Pitcher, & Hay, 1999; Sergeant, Piek, & Oosterlaan, 2006), suggesting 
vestibular and cerebellar involvement. 
Imaging studies report that (a) the cerebellum, right prefrontal cortex, and striatum are 
significantly smaller in children with ADHD (Castellanos et al., 2002; Faraone & Biederman, 
1998), (b) methylphenidate significantly increased brain metabolism in the cerebellum and frontal 
and temporal lobes (Volkow et al., 2004), and (c) caloric stimulation of the inner-ear vestibular 
labyrinth activates the limbic system and neocortex (Vitte et al., 1996), providing a 
neuroanatomical link between vestibular stimulation and the limbic dopaminergic system. 
Dysfunction of the ventral tegmental–limbic dopaminergic system is suspected in ADHD 
(Nieoullon, 2002; Viggiano, Grammatikopoulos, & Sadile, 2003). The basal ganglia and 
cerebellum are important for not only motor control but also cognitive and emotional function 
(Anderson, Lowen, & Renshaw, 2006; Heath, Franklin, & Shraberg, 1979; Jacobsen, Giedd, 
Berquin, & Krain, 1997; Schmahmann, 1997). Andreasen, Paradiso, and O’Leary (1998) and 
Anderson et al. (2006) hypothesized that cerebellar connections with limbic structures and 
prefrontal cortex are important in normal attention and cognition. 
Dysregulation of norepinephrine is associated with labile attention and poor task 
performance. The locus ceruleus and ventrolateral medulla provide norepinephrine stimulation to 
the entire brain, including cerebral and cerebellar cortex. Phasic discharge of the locus ceruleus in 
response to a specific task against a background of low tonic activity results in improved 
performance (Aston-Jones & Cohen, 2005). Thus, dysregulation of the central noradrenergic 
system may play a role in the pathophysiology of ADHD (Lasky-Su et al., 2006; Seidman et al., 
2006), probably involving deficits in catecholamine inhibitory frontostriatal connections. Otolith 
projections provide excitatory input to sympathetic system nuclei, including locus ceruleus and 
subretrofacial nucleus of the ventrolateral medulla (Jian, Acernese, Lorenzo, Card, & Yates, 
2005; Yates, 1992; Yates & Bronstein, 2005; Yates, Goto, & Bolton, 1992; Yates, Goto, Kerman, 
& Bolton, 1993). In contrast, semicircular canal connections are primarily associated with brain 
regions related to acetylcholine. An eighth nerve lesion severing input from both semicircular 
canals and otolith organs significantly increases hippocampal norepinephrine levels, probably 
through vestibular–locus–ceruleus connections (Smith et al., 2005; Zheng, Darlington, & Smith, 
2004). Otolith stimulation increased the activity in locus ceruleus neurons (Marshburn, Kaufman, 
Purcell, & Perachio, 1997), whereas caloric stimulation of semicircular canals inhibited locus 
ceruleus activity (Nishiike, 2003; Nishiike, Takeda, Kubo, & Nakamura, 2001). Previc (1993) 
and Previc and Ercoline (2001) suggested that otolith input is important in the sympathetic 
norepinephrine system, whereas semicircular canal input is important in the parasympathetic 
system. 
Among sensory inputs to the cerebellum, vestibular is unique. Most senses relay through 
synapses in thalamus or brainstem, but some vestibular input enters the cerebellum directly 
without crossing a synapse (Kotchabhakdi & Walberg, 1978a). Vestibular input to the vermis, 
especially inferior, is abundant (Kotchabhakdi & Walberg, 1978b; Zajonc & Roland, 2005). The 
two vestibular end organ components, the semicircular canals and the otolith organs (saccules and 
utricles), sense angular and linear acceleration, respectively. Their central projections differ: 
Semicircular canals target more superior vestibular nuclear regions, otolith projections more 
inferior. Both also project directly to most cerebellar regions (Brodal, 1974; Carpenter, 1988; 
Zajonc & Roland, 2005). 
Previous Studies of Motion Stimulation in ADHD 
In an exploratory crossover study, 18 children 4 to 14 years of age with a hyperkinetic 
reaction diagnosed according to the second edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-II) experienced rotary stimulation of the semicircular canals twice 
weekly for 4 weeks and an equal-time sham condition, with random assignment to order. In a 
specially adapted swivel chair, the head was held in various planes to stimulate each pair of 
semicircular canals in turn by rapid acceleration to 33 rpm. Conners’s scales showed significant 
improvement compared to the sham (Bhatara, Clark, Arnold, Gonsett, & Smeltzer, 1981). 
However, the sham consisted merely of sitting in the same chair used for the rotary treatment and 
talking with the assistant. 
In a later study, 30 DSM-III-diagnosed children with attention deficit disorder with 
hyperactivity had the same rotary motion in a single-blind crossover design with random 
assignment to order (Arnold, Clark, Sachs, Jakim, & Smithies, 1985). All received eyes-open combined 
vestibular and visual stimulation and a control condition. Half the sample also received visual 
rotational stimulation inside an optokinetic drum (visual alone), and the other half received 
semicircular canal stimulation while wearing opaque goggles (vestibular alone). The control 
condition, called tactile–auditory–visual, occupied the children for the same length of time 
looking through a stereoscopic projector (visual), listening to sounds (auditory), and feeling air 
“poofed” onto their skin with a bellows (tactile). The active treatments resulted in a significant 
improvement in behavior from baseline to end of treatment in blinded-teacher-rated behavior. 
The vestibular-alone condition showed the greatest effect, Cohen’s d about 0.5 compared to the 
control condition. 
Comprehensive Motion Apparatus (CMA) 
The CMA differs from technology used in previous studies, which restricted stimulation 
to the semicircular canals. The CMA also stimulates the otolith system, which detects gravity 
and other linear acceleration. It was originally developed and used clinically for rehabilitation of 
neurological patients and treatment of learning disorder. It was always used with “engineered” 
white noise to the right ear. Ferrara et al. (1999) found encouraging open results. 
Learning-disordered children received 30-min treatments 3 times per week for 12 weeks. 
Significant improvements occurred in spelling (34%), word attack (31%), and motor tests. These 
remained improved 6 weeks later. A major criticism of this study was that it did not have a 
control group. Also, children received 20 min of a computerized typing tutorial immediately after 
each treatment, on the rationale that an immediate learning experience could help reorganize 
neurological function during the period of post-CMA plasticity. Therefore, it is unclear whether 
the improvements reported are a result of CMA treatment, the engineered white noise, the 
tutorial, the combination, or nonspecific effects such as statistical regression, history or 
maturation, and Hawthorne (placebo) effect. Furthermore, learning disorder was targeted, and it 
is not clear whether the results could generalize to ADHD without learning disorder. 
Thus, previous work suggested benefit from rotary stimulation of semicircular canals in 
ADHD and from CMA combined stimulation of canals and otolith system in learning disorder, 
but there was no test of the combined stimulation in diagnosed ADHD and no placebo-controlled 
study of the CMA. The study reported here was designed to test these hypotheses: 
Primary hypothesis: 
The CMA shows a clinically and statistically significant benefit for ADHD symptoms 
compared to a credible control condition that includes non-CMA components of the usual CMA 
treatment package. 
Secondary hypothesis: 
The improvement persists for 6 weeks following treatment end. Neuropsychological tests 
also show treatment differences. 
Exploratory questions: 
Do internalizing symptoms or global impairment show a treatment difference? Is there 
any difference by ADHD subtype, suspected presence of learning disorder comorbidity, or prior 
medication? 
Method 
Sample 
Participants were boys and girls ages 6 to 12 with DSM-IV ADHD diagnosed by a child 
psychiatrist assisted by the computerized Diagnostic Interview Schedule for Children, Parent 
Version (Shaffer et al., 1996). They were recruited by ads, by referral from pediatricians and 
school staff, and by a mailing to the patients with an ADHD diagnosis attending the Children’s 
Hospital behavioral health clinics. Inclusion criteria stated that, in addition to DSM-IV diagnosis 
by child psychiatrist and structured interview, each participant was required to have a mean 
rating on the parent’s or teacher’s SNAP-IV (ADHD checklist of DSM-IV symptoms) of 1.7 or 
more on the 0 to 3 scale (Swanson, 1992). The child had to be unmedicated (for ADHD) for 2 
weeks prior to randomization and stay unmedicated during treatment. Exclusion criteria included 
currently in the hospital, in another study, IQ below 75, bipolar disorder, psychosis, or 
neuroleptic drug in the previous 6 months. All parents gave written permission and children gave 
assent using consent forms approved by the university institutional review board. Details of 
sample characteristics are in Table 1. 
Design 
In a randomized, parallel-group design, an experimental group and control group were 
each treated 30 min thrice weekly for 12 weeks, with 6-week follow-up assessment. 
Experimental treatment. 
The CMA is a reclining chair in which the child rotates with programmed gradual 
acceleration to 4 rpm accompanied by rocking and tilting. The main axis of rotation is at waist 
level, offset from the vertical by about 5°, with head reclined about 2 ft. from the axis. The CMA 
provides some semicircular canal stimulation (muted from that in the previous studies, only 4 
rpm) but also otolith system stimulation. The amplitude and direction of linear acceleration 
change as the CMA rotates, rocks, and tilts. The centrifugal force on the head provides 
gravity-like acceleration in the opposite direction (waist to head) from the usual perception of 
gravity. The axial rocking provides anterior–posterior motion; the lateral rocking provides 
additional lateral and some rotary motion. Thus motion is provided in at least six vectors. 
 
Characteristic 
N 
Total Sample  
53
Treatment  
26
Control  
27 
M SD M SD M SD 
Age, years 8.4 1.5 8.5 1.6 9.2 1.4 
 n % n % n % 
Male 46 86.8 23 88.5 23 85.2
Caucasian 47 88.7 23 88.5 24 88.9
 M SD M SD M SD 
Height (in.) 53.3 3.6 52.9 3.6 53.9 3.4
Weight (lb.) 66.7 20.3 75.9 24.1 75.2 16.1
 n % n % n % 
ADHD 
Inattentive type 13 22.6 4 15.4 9 33.3 
Combined type 40 75.5 22 84.6 18 66.7 
Oppositional-defiant disorder 9 17 4 15.4 5 18.5 
Other comorbidity 3 5.7 2 7.7 1 3.7 
Previous ADHD medication or treatment 23 43.4 10 38.5 13 48.1
 M SD M SD M SD 
Wechsler Abbreviated IQ 103.7 12.5 101.4 11.3 105.8 13.5
Wechsler Individual Achievement 94.1 11.7 92.8 9.4 95.4 13.6
Test Screener composite  
Reading 97.7 11.3 96.2 10.0 99.1 12.5 
Math 95.8 13.0 95.7 12.5 95.8 13.7 
Spelling 93.7 12.4 92.7 9.8 94.6 14.7
 n % n % n % 
% with 1.5 SD discrepancy from IQ 17 32.1 8 30.8 9 33.3
Reading 3 5.7 2 7.7 1 3.7 
Math 8 15.1 3 11.5 5 18.5 
Spelling 10 18.9 4 15.4 6 22.2
Table 1 Sample Characteristics 
The sensation is similar to a small boat yawing, pitching, and rocking. As used clinically by the 
developer, Passive Motion Therapeutics, it was always accompanied by specially engineered 
white noise into the right ear via headphones. 
In a quiet darkened room children reclined in the CMA and experienced programmed 
movement for 30 min. Rotation (4 rpm) continued for 1 min and then changed to the opposite 
direction while gently rocking about the 2 axes providing lateral and sagittal motion. The 
participant wore opaque ophthalmic eye shields and an acoustic head set that blocked ambient 
sound and provided the low volume, broad-spectrum white noise engineered by the CMA developer. 
This is consistent with Ferrara et al. (1999). 
Immediately following each session, treatment or control, each participant received a 
20-min academic tutorial consisting of computer-assisted instruction using the Mavis-Beacon 
typing program, as in the Ferrara study, in case this component was necessary to consolidate the 
CMA benefit. 
Control condition. 
The control condition was designed to control for Hawthorne/placebo effect by matching 
factors other than actual CMA motion stimulation: number and duration of sessions, experience of 
reclining in the chair, accompanying engineered white noise, and postsession computer typing 
tutorial. While reclining in the CMA, which rotated 180° once over 30 s, the control participants 
listened to the same white noise, broken in the middle by a 10-min entertaining video. The same 
kind of eye shields were worn, except when viewing the video. 
The control condition was single-blindly masked by presenting this as a study of eighth 
nerve stimulation, which involves both hearing and sense of balance and motion. A brief 
explanation of eighth nerve sensation or perception with equal emphasis on cochlear or auditory 
and canal-otolith vestibular function was given to study participants, with a rationale of why 
promoting better perception in both channels could help learning and behavior. Parents and 
children were told at the beginning that we were comparing different doses and combinations of 
the CMA movement with auditory and visual input. Children and parents were asked not to tell 
the teacher exactly what happened in the session as an extra precaution to maintain the blindness 
of teacher ratings. 
Outcome measures. 
Outcome measures included clinical and neuropsychological measures at baseline, end of 
treatment (posttest, PT) and at 6-week follow-up (FU) and some clinical ratings more frequently 
during treatment. 
Clinical assessments. 
The primary outcome measure was DSM-IV ADHD symptoms rated by parent and 
teacher weekly on a 0 to 3 scale (e.g., SNAP-IV; Swanson, 1992). These 18 symptoms were also 
embedded in the monthly Conners’s Rating Scales (parent and teacher versions; Conners, 2001) 
collected monthly. They have demonstrated validity and sensitivity in previous treatment studies 
(e.g., MTA Cooperative Group, 1999): The Multidimensional Anxiety Scale for Children (March, 
1997) measured possible changes in internalizing pathology, and the Columbia Impairment Scale 
(Bird et al., 1993) measured possible changes in global impairment, both collected monthly and at 
FU. 
Neuropsychological testing. 
Neuropsychological examination on entry (baseline), after 12 weeks of treatment (PT), 
and 6 weeks after treatment end (FU) focused on measures of executive function, attention, 
vigilance, and impulsivity. All tests have normative data by age. The Continuous Performance 
Test (CPT; Conners, 2000) was the primary measure of attention and vigilance. Variables 
included number of omissions and commissions, response speed, variability, and change in 
response speed. The Wisconsin Card Sorting Test (Chelune & Baer, 1986) measures reasoning, 
concept formation, perseveration, and impulsivity (number of breaks in response set). Because the 
study budget did not allow for complete psychoeducational evaluation and clinical diagnosis of 
learning disorder, a proxy variable was constructed from brief achievement and IQ testing at 
screening by Wechsler Individual Achievement Test (Wechsler, 2001) screener and Wechsler 
Abbreviated Scale of Intelligence (Wechsler, 1999). The threshold for the binary proxy variable 
for suspected learning disorder was a 1 standard deviation gap between achievement standard 
score and IQ. This threshold was selected over the more usual 1.5 standard deviations to balance 
group sizes better for the analysis. 
Data analysis. 
The main outcome measure, the average of all 18 ADHD symptoms rated by parent and 
teacher, was related to potential predictors via a linear mixed-effects model (Pinheiro & Bates, 
2000) that included fixed-effects terms for two continuous predictors, time and time squared, and 
three dichotomous indicators—treatment (active vs. control), rater (parent vs. teacher), and 
diagnostic subtype (inattentive vs. combined)—and all possible two-way interactions except for 
time squared. The random effects included participant-specific intercepts and slopes for time and 
rater-specific intercepts within participant. We used the S-PLUS software (Insightful Corp) to fit 
the model. The use of both raters in the same analysis was recommended and used by Conners et 
al. (2001), Swanson et al. (2001), and MTA Cooperative Group (2004), based on Kraemer and 
Thiemann (1989). Alpha of .05 was used; the single primary outcome required no correction. 
Secondary subgroup and follow-up analyses and analyses of secondary measures, 
including neuropsychological tests, were done by simpler repeated measures ANOVAs. Time 
(within participant) had two levels: baseline versus PT (last observation carried forward), 
baseline versus FU, or PT versus FU. Assigned treatment was a between-subjects factor. Age, 
prior use of ADHD medication, IQ achievement discrepancy scores, and diagnostic subtype were 
included as covariates, and the interaction of covariate with treatment assignment was used to 
detect moderator effects, which, when significant, were further explored by subgroup analyses. 
Alpha of .05 was used for the secondary exploratory outcomes. For group comparisons on 
secondary measures, effect sizes (Cohen’s d) were calculated by computing change scores for 
each child, then computing means and standard deviations for change scores of each treatment 
group, then dividing the difference in means by the pooled standard deviation of the means. 
Results 
Of 76 who were screened, 53 (26 active treatment and 27 control condition) were eligible 
and randomized. But 3 immediately dropped out, 2 active and 1 control, leaving 24 treatment and 
26 control participants with usable data for intention-to-treat analyses (at least one weekly 
assessment after randomization). Sample characteristics are shown in Table 1 and did not differ 
significantly between randomly assigned groups. One participant in active treatment was 
terminated at 5 weeks because of protocol violation (starting behavioral treatment program at 
school). In all, 45 participants completed all 12 weeks of treatment, and of these, 43 (19 treatment 
and 24 control) returned for FU. Because FU occurred in the 
 
Note: Treatment ended at Week 12 (posttest [PT]). For parent ratings, N = 24 active treatment and 26 control 
condition for PT, 19 active and 24 control for follow-up. For teacher ratings, N = 17 active and 21 control 
for PT, 8 active and 11 placebo for follow-up. 
Fig. 1. ADHD Symptoms Rated 0 to 3 by Parents and Teachers, by Treatment and Subtype 
summer for 20 participants, teacher FU ratings were incomplete. One control participant started 
atomoxetine during the follow-up interval. No other psychoactive drugs were reported during the 
study, although 43% stopped ADHD medication to be in the trial and all were free to start or 
restart medication after week 12 PT. 
Test of Primary Hypothesis: Superiority of CMA at Posttest 
The primary outcome measure, the average of all 18 ADHD symptoms rated by parent 
and teacher, showed significant improvement over time (t = –7.826, p < .0001 for time; t = 7.273, 
p < .0001 for time2). This represented large improvement (Cohen’s d = 1.09 to 1.30) by combination 
of parent and teacher rating, large improvement (d = 1.37 to 1.75) by parent rating, and medium 
improvement (d = 0.40 to 0.64) by teacher rating in both the treatment and control groups. 
However, the difference between groups in their linear improvement over time was not significant 
(t = -0.386, p = .7 for treatment x time interaction). 
Secondary Hypothesis, Maintenance of Gains at Follow-Up 
At FU, with 19 remaining in the treatment group and 24 in the control group (for parent ratings), 
the active-treatment group maintained its improvement, whereas the control group regressed on 
parent ratings (df = 1, F = 4.173, partial η2 = .094, p = .048 for group difference). This resulted in a 
significant treatment difference (df = 1, F = 4.824, partial η2 = .108, p = .034, d = 0.65) in the 
change PT to FU on the primary outcome (combined parent and teacher ratings), favoring the 
active treatment. However, 
 
 
Note: Week 0 = baseline, Week 12 = posttest, Week 18 = follow-up. ↑ = Higher score favorable; ↓ = Lower 
score favorable. CPRS = Conners Parent Rating Scale long version, CTRS = Conners Teacher Rating Scale 
long version. 
a. Negatively signed effect sizes favor control group. 
b. CPT n = 17. 
†p = .05 to .1. *p < .05. **p < .01. 
Table 3 Outcomes for Secondary Measures: Continuous Performance Task (CPT), Wisconsin Card Sort Test 
(WCST), Multi-Axial Anxiety Scale for Children (MASC), Columbia Impairment Scale (CIS), and Conners’s 
Scales 
 Note: A, B, and C are Week 12 posttest (PT) to Week 18 follow-up (FU) changes favoring active treatment. 
For the last segment of timeline, only participants with FU data are included (17 active, 24 control). From 
PT to FU, active treatment produced significantly more improvement on reaction time interstimulus 
interval change (df = 1, F = 8.82, partial η2 = .192, p = .005, d = 0.93) and standard error by interstimulus 
interval (df = 1, F = 5.48, partial η2 = .129, p = .025, d = 0.74) and a marginal trend on categories of the 
Wisconsin Card Sort (WCS; p = .073, d = 0.52). D, E, and F are baseline to FU changes with significant 
moderation by presence of IQ-achievement discrepancy greater than 1 standard deviation. N = 23 discrepant at 
PT, 18 discrepant at FU, 25 not discrepant. Discrepancy favors active treatment on CPT commission errors (df 
= 1, F = 4.39, partial η2 = .114, p = .044), CPT detectability/d’ (df = 1, F = 6.26, partial η2 = .156, p = .017), 
and WCS perseveration errors (p = .028). 
Fig. 2. Neuropsychological Test Changes 
the overall advantage baseline to FU for active treatment was not significant, even by parent 
rating (df = 1, F = 2.327, partial η2 = .049, p = .13, d = 0.47). 
Covariates in Primary Analysis 
Means of all 18 ADHD symptoms for children with different subtype diagnosis 
(inattentive vs. combined) did not change over time at a significantly different rate (t = -0.692, p 
= .49 for subtype x time interaction in the mixed effects linear analysis). Raters (parents vs. 
teachers) did not differ significantly in rating control versus treatment participants (t = -1.098, p = 
.28 for rater x treatment interaction) or in rating inattentive versus combined subtype (t = -1.347, p 
< .18 for rater x subtype interaction). However, parents reported more improvement over time (t 
= 10.031, p < .0001 for rater x time interaction). Therefore, we heuristically examined parent and 
teacher ratings separately (Table 2 and Figure 1). Because inattentive type was unevenly 
distributed, we also examined difference by diagnostic subtype (inattentive vs. combined) in 
Table 2 and Figure 1 and covaried subtype in secondary analyses, even though the uneven 
distribution was not significant (χ2 = 2.305, df 1, p = .13). 
Cognitive-neuropsychological objective test outcomes and secondary clinical outcomes are 
shown in Table 3 and Figure 2. From baseline to PT, there was no significant difference between 
treatment groups. However, from baseline to FU the active treatment (n = 17) was significantly 
superior to the control condition (n = 24) on commission errors of the CPT (df = 1, F = 5.38, 
partial η2 = .137, p = .027, d = 0.78), apparently based mainly on medium-sized (d = 0.56) 
continued improvement in the active-treatment group following the PT, which in itself did not 
reach significance (df = 1, F = 3.14, partial η2 = .078, p = .085). From PT to FU, the active 
treatment showed significantly more improvement on reaction time interstimulus interval change 
(df = 1, F = 8.82, partial η2 = .192, p = .005, d = 0.93) and standard error by interstimulus interval 
(df = 1, F = 5.48, partial η2 = .129, p = .025, d = 0.74) and showed a marginal trend on categories 
of the Wisconsin Card Sort (p = .073, d = 0.52). 
In moderator analyses, a discrepancy of greater than 1 standard deviation between IQ and 
achievement standard score was used as a proxy for suspected mild learning disorder (n = 18 
discrepant, 25 not discrepant available at FU). Discrepancy was associated with more benefit of 
CMA treatment compared to control from baseline to FU on CPT commission errors (df = 1, F = 
4.39, partial η2 = .114, p = .044), CPT detectability/d’ (df = 1, F = 6.26, partial η2 = .156, p = 
.017), and WCS perseveration errors (p = .028). Caregiver ratings showed no significant 
moderator effects. Parent ratings showed a significant time x previous medication interaction (df 
= 1, F = 4.86, partial η2 = .097, p = .033 at endpoint, p = .034 at FU) on all 18 ADHD symptoms, 
mainly accounted for by the hyperactive-impulsive symptoms (df = 1, F = 6.78, partial η2 = 
.136, p = .013 at PT, p = .022 at FU). Teacher ratings showed similar interaction at FU (df = 1, F 
= 5.088, partial η2 = .230, p = .038), accounted for by hyperactive-impulsive symptoms (df = 1, 
F = 9.09, partial η2 = .348, p = .008). Those with no previous medication improved more than 
did those who had previous medication, but the treatment difference between CMA and control 
condition was not significant. 
Adverse events were unremarkable, totaling 30 for treatment and 34 for control group. 
Nausea occurred in 4 and 3, respectively. One active-treatment participant dropped out because 
of mild nausea on the first treatment; another developed evening headaches on treatment days 
toward the end of the 12 weeks. Vital signs, height, and weight showed no significant differences. 
Discussion 
This report illustrates the importance of control conditions in trials of intensive, unusual, 
or glamorous treatments for ADHD and the importance of blinding the raters. Without the control 
condition, the improvement on caregiver ratings shown in this study at treatment end would have 
been impressive. In fact, the standardized pre–post effect size (Cohen’s d, the number of standard 
deviations difference, 1.34) and the improvement in the raw SNAP mean (from 2.04 to 1.35) 
over the 12-week treatment on parent ratings of symptoms was comparable to that shown at 3 
months (d = 1.32, SNAP mean improvement 2.00 to 1.32) by the proven medication 
management algorithm of the MTA and nominally superior to the MTA multicomponent 
behavioral treatment (d = 0.61, SNAP mean improvement 1.96 to 1.56). However, the equally 
impressive improvement on the control condition showed that the improvement could not be 
credited to a specific effect of the CMA. Rather, it was mainly because of nonspecific effects 
(placebo expectation, maturation, etc.) or unintended specific effects of components shared by 
control and active treatments. Curiously, the improvement dissipated between PT and FU in the 
control group but not in the active-treatment group. The differential improvement in CPT 
commission errors from baseline at FU but not at PT could raise a question about possible 
sleeper effect, which could be compatible with the FU difference in primary outcome. 
Two previous studies reported significant improvement in ADHD behavior compared to a 
control condition following 4 weeks of vestibular stimulation using teacher and parent rating 
scales similar to those used in the current study. Among possible reasons for the different results 
in this study could be that the control conditions in the previous studies were less credible so that 
they did not control for expectation (and the treatments in both studies were ineffective), that the 
control condition in this one was not ineffective, or that the treatment in this one was not as 
effective as in the previous studies. 
The stimulation in both previous studies focused on the semicircular canals and attempted 
to isolate them from the otolith system. Head position was controlled to present a series of 10 
stimuli to each of the paired horizontal semicircular canals and the two sets of paired vertical 
semicircular canals. The head was centered over the axis of rotation to minimize otolith 
stimulation. The stimulus to the semicircular canals was intense, with rapid acceleration to 33 
rpm (100.0° per s), continuing for 60 s and then stopping impulsively, resulting in vertigo and 
nystagmus. The intensity was reflected in stomach awareness as reported by most participants; 
several reported nausea, and a few sessions were terminated prematurely to prevent vomiting. 
Participants often slept on the ride home. 
In contrast, the CMA stimulus was mixed and milder. The CMA accelerated to only 4.0 
rpm (12.1° per s). There was no impulsive stop but a gradual deceleration to 4.0 rpm in the 
opposite direction over 10 s. However, there was significant otolith stimulation, with axis of 
rotation through the hips. The head, located about 20 in. from the axis of rotation, was exposed to 
mild centrifugal force, linear rather than rotary. Although several participants reported stomach 
awareness, there was little nausea, and none were drowsy or slept on the way home. 
Thus, there is a possibility that the combined otolith and semicircular canal stimulation, 
which we believed would be superior to semicircular canal stimulation alone, was actually 
inferior through some sort of interference or competition or that the intensity of semicircular 
canal stimulus was not adequate with the CMA. 
Limitations 
The size of this sample had power to detect only large effects. However, inspection of raw 
data (Table 2) up to treatment end at Week 12 suggests that there was not a Type II error from 
inadequate power for the primary analysis. Nevertheless, it is possible that a small to moderate 
baseline to FU effect was missed in view of the significant differential change from PT to FU 
favoring the CMA on the primary outcome and a few objective secondary measures. In fact, 
Cohen’s d for baseline to FU on the primary outcome measure was 0.47, which would have 
required a sample of 130 to detect statistical significance with 80% power. On the other hand, the 
significant results on some secondary analyses could have resulted from experiment-wise error in 
the absence of correction for multiple tests. Another limitation is generalizability of the sample. 
Families able and willing to come for treatments thrice weekly for 12 weeks may not be 
representative of those with ADHD. Another limitation is lack of double blindness; single 
blinding (i.e., of patient, parent, and teacher but not treatment staff) was the best that could be 
done. However, the large improvement in parent ratings (the measure most susceptible to placebo 
effects) in the control group seems evidence that blinding was effective. In fact, the more 
objective neuropsychological measures favored the active treatment more than did parent ratings. 
A more severe limitation is that the complexity of the control condition, although good for the 
credibility of the blind, may have resulted in unintended therapeutic effects. The engineered white 
noise and the typing tutorial may have some benefit beyond the nonspecific effect of intense 
involvement in an unusual treatment three times a week with an interested adult. Therefore, the 
failure of significance on the main outcome measure and most secondary measures cannot 
provide a firm basis for concluding that the whole treatment package is ineffective, only that the 
CMA is not an essential component of any therapeutic effect that may be involved. Furthermore, 
the lack of differential effect may not generalize to more intense vestibular stimulation or that 
focused on the semicircular canals. 
Conclusion 
On the basis of the current study, the CMA cannot be recommended for ADHD, at least 
combined type without comorbid learning disorder. It is not clear whether this conclusion applies 
to other forms of vestibular stimulation, more intense or focused on semicircular canals. It does 
appear that the treatment is a safe way of eliciting a strong placebo effect, a therapeutic tool 
recommended by Weintrob (2005). The improvement (presumably placebo) was impressive, enough 
so that of the 43 families returning for 6-week FU, only 1 (in the control group) had found it 
necessary to obtain medication posttreatment, even though 43% had been medicated prior to study 
entry. 
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